Novanta Inc.: Business Overview, Financials & Competitive Analysis
Novanta Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Novanta's proprietary precision technology and emerging robotics exposure position it well for long-term growth, despite current macroeconomic pressures requiring operational optimization. Q3 2025 showed bookings growth of 17% YoY with book-to-bill of 1.03x and adjusted EBITDA of $58.1M. The company reiterated product-driven growth and provided 2026 mid-single-digit organic growth expectations.
What is Novanta Inc.'s industry? Novanta Inc. (novanta.com) operates in Precision Manufacturing & Photonics / Medical Devices / Industrial Automation. AskCyborg classifies Novanta Inc. under Precision Manufacturing & Photonics / Medical Devices / Industrial Automation in its company registry.
Novanta manufactures photonic and motion-control components for medical equipment and industrial technology markets, operating in two segments: Automation Enabling Technologies and Medical Solutions. The company is a ...
Cyborg Score thesis
Novanta's proprietary precision technology and emerging robotics exposure position it well for long-term growth, despite current...
Read the full analyst-debate transcript →Get the Latest Novanta Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNovanta Inc. Overview
Pro stress-test →Novanta manufactures photonic and motion-control components for medical equipment and industrial technology markets, operating in two segments: Automation Enabling Technologies and Medical Solutions. The company is a leading supplier of core technology solutions combining deep proprietary expertise in precision medicine and manufacturing, medical solutions, and robotics and automation to engineer core components and sub-systems that deliver extreme precision and performance.
Strategic Profile
Pro stress-test →Novanta signed a major $50 million warehouse robotics contract with a leading e-commerce company, with revenue commencing in 2026. The company is collaborating with over 10 leading humanoid robotics players across North America and Europe on multiple projects with significant content.
Competitive Landscape
Pro stress-test →The Medical Solutions segment generates majority revenue from medical insufflators, pumps, visualization solutions, and wireless technologies. Novanta competes with larger diversified industrial suppliers and specialized precision component manufacturers. Key competitors include Teledyne Technologies, II-VI Incorporated (now Coherent), and various laser/motion control specialists.
Industry Context
Novanta Inc. operates in Precision Manufacturing & Photonics / Medical Devices / Industrial Automation.
Key facts
Founded: 1968 · Headquarters: Bedford, Massachusetts · Revenue: $960M · Market cap: $5.19B